APAC respiratory care market poised for growth as home healthcare expands
Private hospitals and sleep laboratories are creating opportunities for device manufacturers.
Asia-Pacific is projected to be the fastest-growing respiratory care devices market, driven by healthcare infrastructure expansion, rising treatment demand, and efforts to improve medical oxygen access, according to Wissen Research.
Investments in hospital capacity, critical-care infrastructure, and home healthcare services across China, India, Japan, South Korea, and Australia are supporting regional growth.
Expanding private hospitals, specialty respiratory centres and sleep laboratories are also creating opportunities for device manufacturers, alongside efforts to scale up medical oxygen systems.
The regional outlook comes as the global respiratory care devices market is projected to grow from $25.5b in 2026 to $36.7b by 2031, at a compound annual growth rate of 7.6%, according to the research firm.
Demand is being driven by chronic respiratory conditions, including chronic obstructive pulmonary disease and asthma, as well as rising sleep apnoea diagnoses and ageing populations.
Equipment used to treat and monitor these conditions includes ventilators, continuous positive airway pressure and bilevel positive airway pressure systems, oxygen concentrators, nebulisers, and connected monitoring devices.
“Respiratory care is shifting from hospital-based support toward non-invasive ventilation, connected devices, and home-based respiratory care,” the report said.
Remote monitoring platforms allow healthcare providers to track treatment adherence and identify problems without requiring patients to attend hospitals for every assessment.
However, medical oxygen access remains a challenge in some low- and middle-income settings.
Citing the World Health Organization, Wissen Research noted gaps in uninterrupted oxygen availability, with effective treatment depending on reliable generation, distribution, delivery systems, power supply, and trained personnel.
North America held the largest regional share of the respiratory care devices market in 2025, supported by high healthcare spending, established hospital and homecare networks, and a strong medical technology sector.